Skip to main content
. 2024 Jan 6;147(1):11. doi: 10.1007/s00401-023-02662-1

Fig. 1.

Fig. 1

Outcome of patients with IDH-mutant astrocytoma stratified according to CNS WHO grade and CDKN2A copy number status. (a, b) PFS (a) and OS (b) of the entire cohort of patients with IDH-mutant astrocytomas stratified by CNS WHO grade 2, 3 or 4. (cf) PFS (c, e) and OS (d, f) of the entire cohort of patients with IDH-mutant astrocytoma (c, d) or IDH-mutant astrocytoma of CNS WHO grade 4 only (e, f)